Hologic Inc. Stock
Hologic Inc. Stock
We can see a decrease in the price for Hologic Inc.. Compared to yesterday it has lost -€1.000 (-1.550%).
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Hologic Inc..
With a target price of 71 € there is a slightly positive potential of 10.94% for Hologic Inc. compared to the current price of 64.0 €.
So far the community has only identified positive things for Hologic Inc. stock. The most positive votes were given for criterium "Unique positioning".
Pros and Cons of Hologic Inc. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hologic Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hologic Inc. | -1.550% | -0.775% | -0.775% | -11.111% | -7.246% | -10.264% | 4.065% |
| Veeva Systems A | -2.530% | -8.494% | -25.810% | -14.424% | -6.422% | 16.328% | -12.755% |
| Thermo Fisher Scientific Inc. | -1.250% | -0.885% | -3.923% | -2.812% | -2.393% | -9.506% | 25.280% |
| Waters Corp. | -2.270% | -1.851% | -0.090% | -8.541% | -6.046% | 4.504% | 67.889% |
Comments
Hologic (NASDAQ:HOLX) was given a new $78.00 price target on by analysts at Evercore ISI. They now have an "outperform" rating on the stock.
Show more
Ratings data for HOLX provided by MarketBeat
Hologic (NASDAQ:HOLX) had its price target raised by analysts at Argus from $80.00 to $90.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HOLX provided by MarketBeat
Hologic (NASDAQ:HOLX) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HOLX provided by MarketBeat
News
Hologic (HOLX) Q3 Revenue Beats 1%
Hologic (NASDAQ:HOLX), a global medical technology company specializing in diagnostics and women’s health, reported financial results for the third quarter of fiscal 2025 on July 30, 2025. The most
